| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +0.00% | +9.20% | +1.93% | +7.27% | +7.27% | — |
| 14d | 2 | +50.00% | +22.40% | +1.22% | +21.19% | +21.19% | — |
| 30d | 2 | +0.00% | +41.01% | +2.29% | +38.71% | +38.71% | — |
| 60d | 2 | +0.00% | +80.50% | +6.51% | +74.00% | +74.00% | — |
| 90d | 2 | +0.00% | +78.65% | +11.07% | +67.58% | +67.58% | — |
| 180d | 2 | +100.00% | -25.79% | +16.27% | -42.05% | -42.05% | — |
| 1y | 2 | +100.00% | -33.28% | +30.55% | -63.83% | -63.83% | — |
| 2y | 2 | +0.00% | +33.89% | +49.45% | -15.56% | -15.56% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| GANX GAIN THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 825 | — | — | 26,588 | Mar 26, 2024 | Mar 28, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE Chief Executive Officer | 637 | — | — | 6,376 | Mar 26, 2024 | Mar 28, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 637 | — | — | 27,225 | Mar 26, 2024 | Mar 28, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE Chief Executive Officer | 6,085 | $4.06 | $24.7K | 21,140 | Mar 26, 2024 | Mar 28, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 18,750 | — | — | 25,763 | Mar 26, 2024 | Mar 28, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE Chief Executive Officer | 18,750 | — | — | 56,250 | Mar 26, 2024 | Mar 28, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE Chief Executive Officer | 825 | — | — | 8,250 | Mar 26, 2024 | Mar 28, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 370,000 | — | — | 370,000 | Mar 21, 2024 | Mar 25, 2024 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE Chief Executive Officer | 206 | $2.46 | $507 | 5,286 | Dec 21, 2023 | Dec 22, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE Chief Executive Officer | 637 | — | — | 7,013 | Dec 20, 2023 | Dec 22, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 637 | — | — | 5,492 | Dec 20, 2023 | Dec 22, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,820 | $2.50 | $4.5K | 4,855 | Dec 7, 2023 | Dec 14, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 825 | — | — | 6,675 | Oct 1, 2023 | Oct 3, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE Chief Executive Officer | 825 | — | — | 9,075 | Oct 1, 2023 | Oct 3, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 2,550 | — | — | 5,850 | Sep 20, 2023 | Sep 22, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE Chief Executive Officer | 2,550 | — | — | 7,650 | Sep 20, 2023 | Sep 22, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 3,300 | — | — | 3,300 | Jul 1, 2023 | Jul 5, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | SALE Chief Executive Officer | 3,300 | — | — | 9,900 | Jul 1, 2023 | Jul 5, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Mar 23, 2023 | Mar 27, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Mar 23, 2023 | Mar 27, 2023 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,900 | — | — | 60,900 | Sep 20, 2022 | Sep 22, 2022 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 10,200 | — | — | 10,200 | Sep 20, 2022 | Sep 22, 2022 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 79,200 | — | — | 79,200 | Jul 15, 2022 | Jul 19, 2022 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 13,200 | — | — | 13,200 | Jul 15, 2022 | Jul 19, 2022 ↗ | View → |
| GANX GAIN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | $5.86 | $1.17M | 200,000 | Dec 23, 2021 | Dec 28, 2021 ↗ | View → |